Cardiogenic shock is associated with substantial morbidity and mortality. Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little evidence exists to guide the ...

Windtree Therapeutics, Inc. announced that it is preparing for an interim analysis of its SEISMiC C Phase 2 study of istaroxime, targeting results for July 2025. This global, placebo-controlled, ...

Cardiogenic shock is characterized by depression of cardiac function that leads to low blood pressure, coronary ischemia, and further decreased cardiac contractility resulting in tissue hypoxemia. The ...

Diabetic shock is a state of severe low blood sugar, known as hypoglycemia. Diabetic shock is an emergency and can lead to a diabetic coma without treatment. Hypoglycemia, or low blood sugar levels, ...

Adrenomed AG is translating the concept of precision medicine to acute care with a biomarker-guided antibody therapy for sepsis and septic shock. With a mortality rate of 20–30% in developed countries ...

UC San Francisco’s Heart and Vascular Center has been recognized by the American Heart Association (AHA) for its participation in a new Cardiogenic Shock Registry. The purpose of the registry is to ...

The phrase "going into shock" is a common line in medical dramas, but the actors don't always explain what that means. Shock is a sudden drop in blood flow in your body, and it comes with serious ...

The survival benefit associated with the use of Impella CP (Abiomed) for patients with STEMI-related cardiogenic shock in the DanGer Shock trial progressively shrank as the time between symptom onset ...